Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Chavanet

Showing results (131-140 of 141) with videos related to

Pageof 15
Sort By:
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|January 16, 2007
Incidence of and risk factors for severe liver toxicity in HIV-infected patients on anti-tuberculosis treatmentE Pukenyte, F X Lescure, D Rey, et al.
Medecine Et Maladies Infectieuses|March 21, 2016
Abdominal tuberculosis in a low prevalence countryA Fillion, P Ortega-Deballon, S Al-Samman, et al.
Annales De Cardiologie Et D'Angeiologie|January 13, 2004
[Is there an increased risk for cardiovascular disease in HIV-infected patients on antiretroviral therapy?]M Duong, Y Cottin, M Froidure, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|January 13, 2016
Impact of microbiological samples in the hospital management of community-acquired, nursing home-acquired and hospital-acquired pneumonia in older patientsA Putot, J Tetu, S Perrin, et al.
Annales Pharmaceutiques Francaises|May 1, 2014
Generic vancomycin products: Analysis of serum concentrations in patients with acute myeloid leukemiaA Monnier, C Malbranche, P Fagnoni, et al.
Presse Medicale (Paris, France : 1983)|March 26, 2004
[Predictive factors of virological response to primary antiretroviral treatment]J-F Faucher, B Challier, C Chirouze, et al.
Epidemiology and Infection|January 13, 2009
Markov modelling of HIV infection evolution in the HAART eraC Binquet, G Le Teuff, M Abrahamovicz, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|January 28, 2021
Is there a need to widely prescribe antibiotics in patients hospitalized with COVID-19?F Moretto, T Sixt, H Devilliers, et al.
The Journal of Antimicrobial Chemotherapy|November 28, 2008
High rate of early virological failure with the once-daily tenofovir/lamivudine/nevirapine combination in naive HIV-1-infected patientsD Rey, B Hoen, P Chavanet, et al.
Journal of Viral Hepatitis|July 8, 2000
Hepatitis C virus co-infection is a negative prognostic factor for clinical evolution in human immunodeficiency virus-positive patientsL Piroth, M Grappin, L Cuzin, et al.
Pageof 15

Showing results (131-140 of 141) with videos related to

Sort By:
Pageof 15
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|January 16, 2007
Incidence of and risk factors for severe liver toxicity in HIV-infected patients on anti-tuberculosis treatmentE Pukenyte, F X Lescure, D Rey, et al.
Medecine Et Maladies Infectieuses|March 21, 2016
Abdominal tuberculosis in a low prevalence countryA Fillion, P Ortega-Deballon, S Al-Samman, et al.
Annales De Cardiologie Et D'Angeiologie|January 13, 2004
[Is there an increased risk for cardiovascular disease in HIV-infected patients on antiretroviral therapy?]M Duong, Y Cottin, M Froidure, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|January 13, 2016
Impact of microbiological samples in the hospital management of community-acquired, nursing home-acquired and hospital-acquired pneumonia in older patientsA Putot, J Tetu, S Perrin, et al.
Annales Pharmaceutiques Francaises|May 1, 2014
Generic vancomycin products: Analysis of serum concentrations in patients with acute myeloid leukemiaA Monnier, C Malbranche, P Fagnoni, et al.
Presse Medicale (Paris, France : 1983)|March 26, 2004
[Predictive factors of virological response to primary antiretroviral treatment]J-F Faucher, B Challier, C Chirouze, et al.
Epidemiology and Infection|January 13, 2009
Markov modelling of HIV infection evolution in the HAART eraC Binquet, G Le Teuff, M Abrahamovicz, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|January 28, 2021
Is there a need to widely prescribe antibiotics in patients hospitalized with COVID-19?F Moretto, T Sixt, H Devilliers, et al.
The Journal of Antimicrobial Chemotherapy|November 28, 2008
High rate of early virological failure with the once-daily tenofovir/lamivudine/nevirapine combination in naive HIV-1-infected patientsD Rey, B Hoen, P Chavanet, et al.
Journal of Viral Hepatitis|July 8, 2000
Hepatitis C virus co-infection is a negative prognostic factor for clinical evolution in human immunodeficiency virus-positive patientsL Piroth, M Grappin, L Cuzin, et al.
Pageof 15